Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2010
12/22/2010EP2084172B1 Novel 1,4-benzothiepin-1,1-dioxide derivatives which are substituted with benzyl groups, method for producing drugs containing said compounds and use thereof
12/22/2010EP2081889B1 Sulfonamide derivatives
12/22/2010EP2061774B1 Arylpiperazine derivatives and uses thereof
12/22/2010EP2049540B1 4-amino-3-arylamino-6-arylpyrazolo[3,4-d]pyrimidine derivatives, methods for their preparation and their use as antiviral agents
12/22/2010EP2041100B1 Substituted 5- phenylamino- 1, 3, 4-oxadiaz0l-2-ylcarbonylamino-4-phenoxy-cyclohexane carboxylic acid as inhibitors of acetyl coenzyme a diacylglycerol acyltransferase
12/22/2010EP2029534B1 1h-indol-5-yl-piperazin-1-yl-methanone derivatives
12/22/2010EP2026818B1 Combination of steroids having transporter-enhanced corticosteroid activity
12/22/2010EP2007367B1 Medicated feed premix comprising chlortetracycline hydrochloride
12/22/2010EP2001894B1 Novel bis-2-difluoro-pyrrolo[2,1-c][1,4]benzodiazepine dimmers
12/22/2010EP1984002B1 Trialkylsilylbenzylaminocarboxyindoles, indazoles and indolines and their use in treating cetp-mediated disorders
12/22/2010EP1943230B1 Compounds which have activity at m1 receptor and their uses in medicine
12/22/2010EP1915345B1 Fluoro substituted 2-oxo azepan derivatives
12/22/2010EP1891066B1 Compounds and compositions as protein kinase inhibitors
12/22/2010EP1871353B1 Vitamin k for prevention and treatment of skin rash secondary to anti-egfr therapy
12/22/2010EP1865941B8 Oils of capsaicinoids and methods of making and using the same
12/22/2010EP1845957B1 Method for producing a drug extract that contains hydroxystilbenes
12/22/2010EP1839653B9 Therapeutic agent for sensory disorders
12/22/2010EP1805156B1 Preparation and use of biphenyl-4-yl-carbonylamino acid derivatives for the treatment of obesity
12/22/2010EP1804800B1 Use of 4-(4-methylpiperazin-1-ylmethyl)-n-4-methyl-3-(4-(pyridin-3-yl)pyrimidin-2-ylamino)phenyl¨-benzamide to inhibit the tyrosine kinase receptor c-fms
12/22/2010EP1784396B1 Pyrazole-substituted aminoheteroaryl compounds as protein kinase inhibitors
12/22/2010EP1781601B1 Derivatives of arylsulfonamido-substituted hydroxamic acid as matrix metalloproteinases inhibitors
12/22/2010EP1781299B1 Anti-inflammatory agents
12/22/2010EP1758869B1 Pyridazin-3(2h)-one derivatives and their use as pde4 inhibitors
12/22/2010EP1740166B1 Therapeutic antimicrobial compositions and methods
12/22/2010EP1737819B1 Amino acid and peptide conjugates of arylalkylic acids for cosmetic use
12/22/2010EP1651232B1 Compounds for inflammation and immune-related uses
12/22/2010EP1487787B1 Derivatives and pharmaceutical compositions of n-hydroxyalkyl tetramethylcyclopropane-carboxamide, having anti-epileptic and method for their preparation
12/22/2010EP1453805B1 4-piperidinyl alkylamine derivatives as muscarinic receptor antagonists
12/22/2010EP1419171B1 Methods for the synthesis of a modified hemoglobin solution
12/22/2010EP1412317B1 Retinoid derivatives with antiangiogenic, antitumor and proapoptotic activities
12/22/2010EP1392696B1 Polymorph forms of n-(2,3-dimethyl-5,6,7,8-tetrahydrofuro 2,3-b quinolin-4-yl)-2-(2- oxopyrrolidin -1 -yl)acetamide
12/22/2010EP1390037B1 Use of glucocorticoid receptor-specific antagonists for the treatment of delirium
12/22/2010EP1368013B1 Cyclohexenone derivative for treating diabetic neuropathy
12/22/2010EP1290182B1 Sphingosine kinase and uses thereof
12/22/2010EP1214064B1 Systems for agitated delivery of anti-infective compositions to treat disordered tissue such as cold sores
12/22/2010EP1135496B1 Ucp5
12/22/2010CN201676085U Self-heating indomethacin patch
12/22/2010CN201676082U Burning-caused inflammation eliminating swab for medical use
12/22/2010CN1997373B Phycotoxins and uses thereof
12/22/2010CN1988907B Dual small molecule inhibitors of cancer and angiogenesis
12/22/2010CN1976697B Liver function modifier
12/22/2010CN1928107B Methods for the production of 3-o-deactivated-4'-monophosphoryl lipid a (3d-mla)
12/22/2010CN1914208B Substituted 8'-pyri(mi)dinyl-dihydrospiro-[cycloalklymine]-pyrimido[1,2a]pyrimidin-6-one derivatives
12/22/2010CN1902186B Thiazole and pyrazole derivatives as FLT-3 kinase inhibitors
12/22/2010CN1886380B Benzoimidazole compounds
12/22/2010CN1835722B Transdermal hormone delivery system: compositions and methods
12/22/2010CN1826122B Oxidized phospholipids and application in atherosclerosis treatment thereof
12/22/2010CN1812973B Indazole compounds useful as protein kinase inhibitors
12/22/2010CN1809357B Small molecule Toll-like receptor (TLR) antagonists
12/22/2010CN1806823B Externally applied wind-expelling Chinese medicinal composition plaster
12/22/2010CN1802366B C-glycoside derivatives and salts thereof
12/22/2010CN1741801B Water-soluble anionic bacteriochlorophyll derivatives and their uses
12/22/2010CN1738794B Biguanide and dihydrotriazine derivatives
12/22/2010CN1729158B Adamantyl acetamides as 11-beta hydroxysteroid dehydrogenase inhibitors
12/22/2010CN1713926B Peritoneal dialysis method
12/22/2010CN1662242B Pharmaceutical compositions for the treatment of diseases related to neurotrophines
12/22/2010CN1626133B Medication for treating coronary heart disease
12/22/2010CN1547477B Derivatives of partially desulphated glycosaminoglycans as heparanase inhibitors, endowed with antiangiogenic activity and devoid of anticoagulating effect
12/22/2010CN101925610A Non-hydrolyzable nucleoside di- or tri-phosphate derivatives and uses thereof
12/22/2010CN101925607A Crystalline cinnamide compounds or salts thereof
12/22/2010CN101925606A Compounds comprising a cyclobutoxy group
12/22/2010CN101925605A Tricyclic triazolic compounds
12/22/2010CN101925604A Efficient aspirin prodrugs
12/22/2010CN101925603A Modulators of cystic fibrosis transmembrane conductance regulator
12/22/2010CN101925602A Crystalline form of abacavir that is essentially free of solvent
12/22/2010CN101925601A Enantiomerically pure (-) 2-[1-(7-methyl-2-(morpholin-4-yl)-4-oxo-4h-pyrido[1,2-a]pyrimidin-9-yl)ethylamino]benzoic acid, its use in medical therapy, and pharmaceutical composition comprising it - 026
12/22/2010CN101925600A Stable crystalline salt of (r)-3-fluorophenyl-3,4,5-trifluorobenzylcarbamic acid 1-azabicyclo [2.2.2]oct-yl ester
12/22/2010CN101925599A Biaryl substituted azabicyclic alkane derivatives as nicotinic acetylcholine receptor activity modulators
12/22/2010CN101925597A Solid forms of 1-ethyl-3-(5-(5-fluoropyridin-3-yl)-7-(pyrimidin-2-yl)-1h-benzo[d]imidazol-2-yl)urea
12/22/2010CN101925596A Beta-amino acid derivatives for treatment of diabetes
12/22/2010CN101925595A Phthalazinone derivatives
12/22/2010CN101925590A Aldh-2 inhibitors in treatment of addiction
12/22/2010CN101925586A Novel heterocyclic compounds
12/22/2010CN101925584A Pyrimidine derivatives for treatment of asthma, COPD, allergic rhinitis, allergic conjunctivitis, atopic dermatitis, cancer, hepatitis b, hepatitis c, HIV, HPV, bacterial infections and dermatosis
12/22/2010CN101925583A Pyridazine derivatives useful as fungicides and for treatment of cancer
12/22/2010CN101925582A N-[3-bromo-2-chloro-4-(4, 5-dihydro-1h-imidazol-2-ylmethyl)-phenyl] -methanesulfoamide as alpha-1 adrenergic partial agonist for treatment of incontinence
12/22/2010CN101925581A Novel imidazolinylmethyl aryl sulfonamides
12/22/2010CN101925580A Novel imidazolinylmethyl aryl sulfonamides
12/22/2010CN101925579A Novel imidazolinylmethyl aryl sulfonamides
12/22/2010CN101925578A 6-substituted-thio-2-amino-quinoline derivatives useful as inhibitors of ss-secretase (BACE)
12/22/2010CN101925577A Salt forms of 6-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene derivative, process for their manufacture and pharmaceutical compositions containing same
12/22/2010CN101925576A Kappa selective opioid receptor antagonist
12/22/2010CN101925573A Novel N-(2-amino-phenyl)-amide derivatives
12/22/2010CN101925383A Carboxamide compounds and their use as chemokine receptor agonists
12/22/2010CN101925362A Treatment and prevention of cardiac conditions using two or more isoforms of hepatocyte growth factor
12/22/2010CN101925357A Formulas comprising calcium, magnesium, zinc, and vitamin D3 for prevention and amelioration of osteoporosis
12/22/2010CN101925356A Agent for enhancing anti-tumor effect comprising oxaliplatin liposome preparation, and anti-tumor agent comprising liposome preparation
12/22/2010CN101925355A Fentanyl-containing patch for external use
12/22/2010CN101925354A Anti-inflammatory compositions and combinations
12/22/2010CN101925353A VEGFC production promoter
12/22/2010CN101925352A Compositions comprising nicotinic agonists and methods of using same
12/22/2010CN101925351A Cytostatic composition
12/22/2010CN101925350A Anti - retroviral combination
12/22/2010CN101925348A Biodegradable single-phase cohesive hydrogel
12/22/2010CN101925347A Polysaccharide gel compositions and methods for sustained delivery of drugs
12/22/2010CN101925346A Oral care product and methods of use and manufacture thereof
12/22/2010CN101925301A Tricyclic compounds as modulators of TNF-a synthesis and as pde4 inhibitors
12/22/2010CN101921823A Method for screening SARS corona virus major protease inhibitor from traditional Chinese medicine and screened SARS corona virus major protease inhibitor
12/22/2010CN101921816A Preparation method and use of xanthone derivative
12/22/2010CN101921810A Method for preparing xylitol and L-arabinose mixed crystal from xylose mother liquid
1 ... 1948 1949 1950 1951 1952 1953 1954 1955 1956 1957 1958 1959 1960 1961 1962 1963 1964 1965 1966 1967 1968 ... 7860